-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Previously, Qingwu Yang and others of the Third Military Medical University reported the 90-day results of a study (evaluating endovascular treatment of acute basilar artery occlusion through a national prospective registry [BASILAR]), which compared conventional treatment and basilar artery occlusion ( BAO) Endovascular treatment (EVT) within 24 hours after the onset of secondary acute ischemic stroke
Vascular Stroke
Information about long-term efficacy may be useful for clinical practice and medical policy decision-making
They recently explored the results of clinical follow-up of patients one year later in the BASILAR registry data
The main clinical outcome is the modified Rankin scale one year later, using ordinal logistic regression analysis to adjust the pre-specified prognostic factors to evaluate the odds ratio
They found that out of the 829 patients initially enrolled in BASILAR, 785 patients (94.
The result distribution of the revised Rankin scale is favorable for endovascular treatment rather than traditional treatment (OR=4.
The one-year cumulative mortality rate in the endovascular treatment group was 54.
The one-year cumulative mortality rate in the endovascular treatment group was 54.
The beneficial effect of endovascular treatment on the functional outcome of patients with acute basilar artery occlusion one year later is similar to the 90-day report in the original study
Original source:
Leave a message here
